115 related articles for article (PubMed ID: 25406896)
1. Modulation of human IAPP fibrillation: cosolutes, crowders and chaperones.
Gao M; Estel K; Seeliger J; Friedrich RP; Dogan S; Wanker EE; Winter R; Ebbinghaus S
Phys Chem Chem Phys; 2015 Apr; 17(13):8338-48. PubMed ID: 25406896
[TBL] [Abstract][Full Text] [Related]
2. Cosolvent effects on the fibrillation reaction of human IAPP.
Seeliger J; Estel K; Erwin N; Winter R
Phys Chem Chem Phys; 2013 Jun; 15(23):8902-7. PubMed ID: 23493869
[TBL] [Abstract][Full Text] [Related]
3. Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes.
Jha S; Sellin D; Seidel R; Winter R
J Mol Biol; 2009 Jun; 389(5):907-20. PubMed ID: 19427320
[TBL] [Abstract][Full Text] [Related]
4. The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetes.
Chien V; Aitken JF; Zhang S; Buchanan CM; Hickey A; Brittain T; Cooper GJ; Loomes KM
Biochem J; 2010 Nov; 432(1):113-21. PubMed ID: 20735358
[TBL] [Abstract][Full Text] [Related]
5. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
[TBL] [Abstract][Full Text] [Related]
6. Engineered aggregation inhibitor fusion for production of highly amyloidogenic human islet amyloid polypeptide.
Mirecka EA; Gremer L; Schiefer S; Oesterhelt F; Stoldt M; Willbold D; Hoyer W
J Biotechnol; 2014 Dec; 191():221-7. PubMed ID: 24928165
[TBL] [Abstract][Full Text] [Related]
7. Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.
Peinado JR; Sami F; Rajpurohit N; Lindberg I
FEBS Lett; 2013 Nov; 587(21):3406-11. PubMed ID: 24042052
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
9. The effects of molecular crowding on the amyloid fibril formation of alpha-lactalbumin and the chaperone action of alpha-casein.
Ghahghaei A; Divsalar A; Faridi N
Protein J; 2010 May; 29(4):257-64. PubMed ID: 20496103
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy.
Lopes DH; Meister A; Gohlke A; Hauser A; Blume A; Winter R
Biophys J; 2007 Nov; 93(9):3132-41. PubMed ID: 17660321
[TBL] [Abstract][Full Text] [Related]
11. Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process.
Radovan D; Smirnovas V; Winter R
Biochemistry; 2008 Jun; 47(24):6352-60. PubMed ID: 18498175
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study.
Evers F; Jeworrek C; Tiemeyer S; Weise K; Sellin D; Paulus M; Struth B; Tolan M; Winter R
J Am Chem Soc; 2009 Jul; 131(27):9516-21. PubMed ID: 19583433
[TBL] [Abstract][Full Text] [Related]
13. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.
Kayed R; Bernhagen J; Greenfield N; Sweimeh K; Brunner H; Voelter W; Kapurniotu A
J Mol Biol; 1999 Apr; 287(4):781-96. PubMed ID: 10191146
[TBL] [Abstract][Full Text] [Related]
14. Macromolecular crowding as a suppressor of human IAPP fibril formation and cytotoxicity.
Seeliger J; Werkmüller A; Winter R
PLoS One; 2013; 8(7):e69652. PubMed ID: 23922768
[TBL] [Abstract][Full Text] [Related]
15. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
Abedini A; Raleigh DP
J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
[TBL] [Abstract][Full Text] [Related]
16. The effect of Arg on the structure perturbation and chaperone activity of α-crystallin in the presence of the crowding agent, dextran.
Ghahghaei A; Mohammadian S
Appl Biochem Biotechnol; 2014 Sep; 174(2):739-50. PubMed ID: 25091326
[TBL] [Abstract][Full Text] [Related]
17. Biophysical characterization of two different stable misfolded monomeric polypeptides that are chaperone-amenable substrates.
Natalello A; Mattoo RU; Priya S; Sharma SK; Goloubinoff P; Doglia SM
J Mol Biol; 2013 Apr; 425(7):1158-71. PubMed ID: 23306033
[TBL] [Abstract][Full Text] [Related]
18. The Mitochondrial-Derived Peptides, HumaninS14G and Small Humanin-like Peptide 2, Exhibit Chaperone-like Activity.
Okada AK; Teranishi K; Lobo F; Isas JM; Xiao J; Yen K; Cohen P; Langen R
Sci Rep; 2017 Aug; 7(1):7802. PubMed ID: 28798389
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin.
Törner R; Kupreichyk T; Gremer L; Debled EC; Fenel D; Schemmert S; Gans P; Willbold D; Schoehn G; Hoyer W; Boisbouvier J
Nat Commun; 2022 May; 13(1):2363. PubMed ID: 35501361
[TBL] [Abstract][Full Text] [Related]
20. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
Jeong HR; An SS
Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
